Felix Orben
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology.
Journal: Translational oncology
Published: May 25, 2025
Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany.
Journal: Journal of neuro-oncology
Published: April 01, 2025
Corrigendum to "A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer" [Bioorgan. Chem. 119 (2022) 105505].
Journal: Bioorganic chemistry
Published: March 08, 2024
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 13, 2023
Comparison of endoscopic ultrasound-guided fine-needle aspiration and fine-needle biopsy to generate pancreatic cancer organoids: Randomized trial.
Journal: Endoscopy international open
Published: July 18, 2023
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 23, 2021
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition.
Journal: Cancer communications (London, England)
Published: September 04, 2021
A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer.
Journal: Bioorganic chemistry
Published: June 22, 2021
Last Updated: 09/26/2026